Voloridge Investment Management
OPRX icon

Voloridge Investment Management’s OptimizeRx OPRX Stock Holding History

Voloridge Investment Management’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-19,545
Closed -$535K – 1565
2022
Q2 		$535K Sell
19,545
-19,017
-49% -$564K ﹤0.01% 1293
2022
Q1 		$1.45M Buy
38,562
+9,788
+34% +$433K 0.01% 1043
2021
Q4 		$1.79M Buy
+28,774
New +$2.18M 0.01% 1109

Other funds holding OPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Voloridge Investment Management's OPRX Position: Q3 2022 in Review

Voloridge Investment Management sold out of OptimizeRx (OPRX) in Q3 2022, closing a stake of 19,545 shares — an estimated $535K sold.

Voloridge Investment Management first reported a position in OPRX in Q4 2021 and held it in 3 quarters. The position peaked at $1.79M in Q4 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q3 2022.

  • Voloridge Investment Management reported no remaining OptimizeRx position as of Q3 2022 after selling out during the quarter.
  • Voloridge Investment Management sold 19,545 OptimizeRx shares in Q3 2022, an estimated $535K.
  • Voloridge Investment Management first reported a position in OptimizeRx in Q4 2021 and held it in 3 quarters.
  • Voloridge Investment Management's OptimizeRx position peaked at $1.79M in Q4 2021.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2022.

Based on Voloridge Investment Management's 13F filing for Q3 2022, filed 14 Nov 2022.